The N1‐methyladenosine methyltransferase TRMT61A promotes bladder cancer progression and is targetable by small molecule compounds
Saved in:
| Main Authors: | Jianjian Yin, Xin Fan, Qi Chang, Yuanheng Dai, Tao Wang, Lei Shi, Linlin Yang, Xiaoming Yang, Xudong Zhang, Lei Jin, Tao Liu, Fengmin Shao, Lirong Zhang, Dongkui Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Clinical and Translational Medicine |
| Online Access: | https://doi.org/10.1002/ctm2.70137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TRMT112, a master activator of several methyltransferases modifying factors involved in RNA maturation and translation
by: Can Wang, et al.
Published: (2025-03-01) -
Recognition and cleavage of human tRNA methyltransferase TRMT1 by the SARS-CoV-2 main protease
by: Angel D'Oliviera, et al.
Published: (2025-01-01) -
tRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humans.
by: Mariana Igoillo-Esteve, et al.
Published: (2013-10-01) -
Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential
by: Wenxiang Shen, et al.
Published: (2025-05-01) -
N6-Methyladenosine Methyltransferase Component KIAA1429 Is a Potential Target of Cancer Therapy
by: Junjun Huang, et al.
Published: (2024-10-01)